Recruiting Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489 Conditions Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more Locations Mercy Hospital - FTS — Fort Smith, Arkansas, United States Frederick Health Hospital — Frederick, Maryland, United States Mercy Hospital - SPG — Springfield, Missouri, United States Mercy Hospital - South — St Louis, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLC NCT07139041 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more Locations Not specified View Trial Details
Completed IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC) NCT05118334 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more Locations The First Hospital of Jilin University — Changchun, Jilin, China View Trial Details
